Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

STANDARD BIOTOOLS INC. Director's Dealing 2012

Feb 21, 2012

32853_dirs_2012-02-21_7c5bf3a7-f385-42a1-bbe5-f04d42dc8e40.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FLUIDIGM CORP (FLDM)
CIK: 0001162194
Period of Report: 2012-02-17

Reporting Person: Walder Fredric T (Chief Business Officer)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2012-02-17 Employee Stock Option (Right to Buy) $15.49 A 40000 Acquired 2022-02-16 Common Stock (40000) Direct

Footnotes

F1: 1/48 of the shares subject to the Option vested on the date of grant and 1/48 of the shares subject to the Option will vest on March 1, 2012 and each month thereafter, such that the Option will be fully vested on January 1, 2016.